Global colorectal cancer burden in 2020 and projections to 2040 Y Xi, P Xu Translational oncology 14 (10), 101174, 2021 | 1950 | 2021 |
Linking obesity with colorectal cancer: epidemiology and mechanistic insights P Ye, Y Xi, Z Huang, P Xu Cancers 12 (6), 1408, 2020 | 115 | 2020 |
PPAR-mediated toxicology and applied pharmacology Y Xi, Y Zhang, S Zhu, Y Luo, P Xu, Z Huang Cells 9 (2), 352, 2020 | 85 | 2020 |
Intestinal sulfation is essential to protect against colitis and colonic carcinogenesis P Xu, Y Xi, J Zhu, M Zhang, Z Luka, DB Stolz, X Cai, Y Xie, M Xu, S Ren, ... Gastroenterology 161 (1), 271-286. e11, 2021 | 45 | 2021 |
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1 Y Xi, Y Li, P Xu, S Li, Z Liu, H Tung, X Cai, J Wang, H Huang, M Wang, ... Science Advances 7 (36), eabg9241, 2021 | 43 | 2021 |
Diabetes and gut microbiota Y Xi, PF Xu World Journal of Diabetes 12 (10), 1693, 2021 | 34 | 2021 |
Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes Y Xi, W Wang, L Wang, J Pan, Y Cheng, F Shen, Z Huang Toxicology and Applied Pharmacology 355, 269-285, 2018 | 30 | 2018 |
Triptolide-induced mitochondrial damage dysregulates fatty acid metabolism in mouse sertoli cells Y Cheng, G Chen, L Wang, J Kong, J Pan, Y Xi, F Shen, Z Huang Toxicology letters 292, 136-150, 2018 | 30 | 2018 |
Inhibition of p53 sulfoconjugation prevents oxidative hepatotoxicity and acute liver failure P Xu, Y Xi, P Wang, Z Luka, M Xu, HC Tung, J Wang, S Ren, D Feng, ... Gastroenterology 162 (4), 1226-1241, 2022 | 26 | 2022 |
Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway J Pan, F Shen, K Tian, M Wang, Y Xi, J Li, Z Huang Toxicology in Vitro 58, 187-194, 2019 | 24 | 2019 |
Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes Y Xi, Y Zhang, J Pan, S Chen, S Lu, F Shen, Z Huang Toxicology letters 318, 1-11, 2020 | 19 | 2020 |
Therapeutic potentials of fasudil in liver fibrosis Y Xi, PF Xu World Journal of Gastroenterology 27 (45), 7859, 2021 | 6 | 2021 |
Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis P Xu, Y Xi, JW Kim, J Zhu, M Zhang, M Xu, S Ren, D Yang, X Ma, W Xie Acta Pharmaceutica Sinica B 14 (3), 1241-1256, 2024 | 4 | 2024 |
Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose HC Tung, JW Kim, J Zhu, S Li, J Yan, Q Liu, I Koo, SA Koshkin, F Hao, ... Science Translational Medicine 16 (766), eadk8446, 2024 | 1 | 2024 |
The de-sulfinylation enzyme sulfiredoxin-1 attenuates hepatic stellate cell activation and liver fibrosis by modulating the PTPN12-NLRP3 axis JW Kim, HC Tung, M Ke, P Xu, X Cai, Y Xi, M Xu, S Ren, Y Huang, ... Hepatology, 10.1097, 2024 | 1 | 2024 |
Intestinal Sulfation is Essential to Protect Against Colitis‐Associated Colonic Carcinogenesis P Xu, Y Xi, J Zhu, M Zhang, Z Luka, D Stolz, X Cai, Y Xie, M Xu, S Ren, ... The FASEB Journal 35, 2021 | | 2021 |
PAPSS2 ablation prevents acetaminophen‐induced hepatotoxicity in mice P Xu, P Wang, Y Xi, Y An, M Xu, S Ren, X Ma, W Xie The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by Y Xi, Y Zhang, J Pan, S Chen, S Lu, F Shen, Z Huang | | 2019 |
Tanshinone I prevents cisplatin-induced cytotoxicity through Nrf2 activation in human renal proximal tubular epithelial cells Y Wang, Y Xi, Y Peng, F Shen, Z Deng, X Zhang, L Hu, S Han, Z Huang, ... LATIN AMERICAN JOURNAL OF PHARMACY 37 (11), 2159-2166, 2018 | | 2018 |
The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis JW Kim, HC Tung, M Ke, P Xu, X Cai, Y Xi, M Xu, S Ren, Y Huang, ... Hepatology, 10.1097, 0 | | |